The P2Y1 receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation - Further evidence for a distinct P2 receptor responsible for adenylyl cyclase inhibition

Thrombosis and Haemostasis

Volumn 81, Issue 5, 1999, Pages 775-781

  Léon, Catherine ^a   Vial, Catherine ^a   Gachet, Christian ^a   Ohlmann, Philippe ^a   Hechler, Béatrice ^a   Cazenave, Jean Pierre ^a   Lecchi, Anna ^b   Cattaneo, Marco ^b  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENYLATE CYCLASE; CALCIUM ION; PURINE P2 RECEPTOR; PURINE P2Y1 RECEPTOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CASE REPORT; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; RNA ANALYSIS; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; THROMBOCYTE SHAPE; TRANSCRIPTION TERMINATION; BLOOD; BLOOD CLOTTING DISORDER; DRUG EFFECT; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY;

ADENOSINE DIPHOSPHATE; ADENYLATE CYCLASE; BASE SEQUENCE; BLOOD COAGULATION DISORDERS; CLONING, MOLECULAR; HUMANS; MOLECULAR SEQUENCE DATA; PLATELET AGGREGATION; RECEPTORS, PURINERGIC P2;

EID: 0033128384     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614570     Document Type: Article

References (35)

1. Macfarlane DE. Agonists and receptors: adenosine diphosphate. In: Responses and Metabolism. Holmsen H (ed). 1987; 19-36.
2. Webb TE, Simon J, Krishek BJ, Bateson AN, Smart TG, King BF, Burnstock G, Barnard EA. Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett 1993; 324: 219-25.
3. 1 purinoceptor. Br J Pharmacol 1996; 118: 167-73.
4. 1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett 1997; 403: 26-30.
5. 1 receptor: similarities to the platelet ADP receptor. Mol Pharmacol 1998; 53: 727-33.
6. 1 receptor. Mol Pharmacol 1996; 50: 1323-9.
7. 1 receptor is necessary for ADP-induced platelet aggregation. Blood 1998; 92: 152-9.
8. 1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 1998; 273: 2030-4.
9. 1 purinoceptor in ADP-induced platelet activation. FEBS Lett 1998; 422: 291-5.
10. Humphries RG, Tomlinson W, Ingall AG, Cage PA, Leff P. FPL 66096LT: a novel, highly potent and selective antagonist at human platelet P2T-receptors. Br J Pharmacol 1994; 113: 1057-63.
11. 1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel. Br J Haematol 1998; 103: 858-66.
12. Daniel JL, Dangelmaier C, Lin L, Ashby B, Smith B, Kunapuli S. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 1998; 273: 2024-9.
13. ADP-receptors. Br J Pharmacol 1998; 124: 157-64.
14. Jin J, Kunapuli SP. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA 1998; 95: 8070-4.
15. 2 proteins. Biochem J 1995; 312: 775-9.
16. 1 purinoceptors in human platelets and megakaryoblastic cell lines. Thromb Haemost 1997; 78: 1500-4.
17. 1 purinoceptor expressed on human platelets. Biochem Biophys Res Comm 1998; 242: 525-8.
18. 1 purinoceptor in human platelets. Molecular cloning and functional characterization after heterologous expression. J Biol Chem 1998; 273: 11544-7.
19. 1 receptor, an adenosine triphosphate-gated cation channel, is expressed in human platelets but not in human blood leukocytes. Blood 1998; 91: 3172-81.
20. Mahaut-Smith MP, Sage SO, Rink TJ. Rapid ADP-evoked currents in human platelets recorded with the nystatin permeabilized patch technique. J Biol Chem 1992; 267: 3060-5.
21. 1 not P2T purinoceptors in human platelets. J Biol Chem 1996; 271: 2879-81.
22. Cattaneo M, Lecchi A, Randi AM, McGregor JL, Mannuci PM. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood 1992; 80: 2787-96.
23. Nurden P, Savi P, Heilmann E, Bihour C, Herbert JM, Maffrand JP, Nurden A. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. J Clin Invest 1995; 95: 1612-22.
24. Gachet C, Cattaneo M, Ohlmann P, Hechler B, Lecchi A, Chevalier J, Cassel D, Manucci, PM, Cazenave JP. Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br J Haematol 1995; 91: 434-44.
25. 33P]2MeSADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Thromb Haemost 1997; 77: 986-90.
26. Cazenave JP, Hemmendinger S, Beretz A, Sutter-Bay A, Launay J. L'agrégation plaquettaire: outil d'investigation clinique et d'étude pharmacologique. Méthodologie. Ann Biol Clin 1983; 41: 167-79.
27. 1 purinoceptor. Gene 1996; 171: 295-7.
28. Sambrook J, Fritsh EF, Maniatis T. Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory Press; 1989.
29. Munson PJ, Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980; 107: 220-39.
30. Breathnach R, Chambon P. Organization and expression of eukaryotic split genes coding for proteins. Annu Rev Biochem 1981; 50: 349-83.
31. 1 purinoceptor. Biochem Biophys Res Commun 1996; 218: 783-8.
32. Lanza F, Beretz A, Stierlé A, Hanau D, Kubina M, Cazenave JP. Epinephrine potentiates human platelet activation but is not an aggregating agent. Am J Physiol 1988; 255: 1276-88.
33. Savi P, Pflieger AM, Herber JM. cAMP is not an important messenger for ADP-induced platelet aggregation. Blood Coag Fibrin 1996; 7: 249-52.
34. Lévy-Toledano S, Maclouf J, Rosa J-P, Gallet C, Vallès G, Nurden P, Nurden AT. Abnormal tyrosine phosphorylation linked to a defective interaction between ADP and its receptor on platelets. Thromb Haemost 1998; 80: 463-8.
35. Savi P, Artçanuthurry V, Bornia J, Grelac F, Maclouf J, Levy-Toledano S, Herbert J-M. Effect of clopidogrel treatment on ADP-induced phosphorylations in rat platelets. Brit J Haematol 1997; 97: 185-91.